Trial intelligence / Profile preview

High-dose Antioxidants for CSC

NCT00963131Phase 2Completed

Sponsor
Prince of Songkla University
Start
Dec 2004
Primary completion
Dec 2008
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of ICaps in Central Serous Chorioretinopathy (CSCR), sponsored by Prince of Songkla University. Started Dec 2004; status: completed.

02

Drugs

ICaps
03

Conditions

Central Serous Chorioretinopathy (CSCR)

Beyond the preview

Go deeper on NCT00963131.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00963131.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call